English
United States
Sign in
Tip from find-more-books.com
Similar books
More/other books that might be very similar to this book
Search tools
Book recommendations
Latest news
Advertising
FILTER
- 0 Results
Lowest price: 79.25 €, highest price: 85.97 €, average price: 81.19 €
Current Clinical Oncology: Breast Cancer in the Post-Genomic Era - Giordano, Antonio (Hrsg.) / Normanno, Nicola (Hrsg.)
book is out-of-stock
(*)
Giordano, Antonio (Hrsg.) / Normanno, Nicola (Hrsg.):
Current Clinical Oncology: Breast Cancer in the Post-Genomic Era - Paperback

2013, ISBN: 9781607614661

[ED: Taschenbuch / Paperback], [PU: Humana Press Springer, Berlin], AUSFÜHRLICHERE BESCHREIBUNG: Breast Cancer is the most common tumor in women and the second leading cause of cancer deaths worldwide. Due to breakthroughs in gene profiling, the knowledge of the pathophysiology of the mammary gland had greatly increased over the last decade. In Breast Cancer in the Post Genomic Era, Antonio Giordano, Nicola Normanno, and a panel of international authorities in their field provide a comprehensive approach to the biology, diagnosis, prevention, and treatment of human breast carcinoma.The book provides a comprehensive approach to breast cancer, describing the use of gene profiling techniques to distinguish specific features of individual carcinomas, as well as emerging novel therapeutic approaches to treatment. Additional chapters cover the use of transgenic mice to model human breast cancer and the role of the EGF-CFC family in mammary gland development and neoplasia. Breast Cancer in the Post Genomic-Era succeeds in looking at breast cancer pathogenesis, diagnosis, and treatment under a more comprehensive light, and is a valuable resource for any Radiation or Surgical Oncologist, Cancer Biologist or Pathologist. INHALT: Potential Contributors and Temptative TitlesSection I: The biology of the mammary gland:Jose Russo, Breast Cancer Research Laboratory, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USATitle: Mammary gland development Gilbert H. Smith Mammary Biology and Tumorigenesis Laboratory, Center for Cancer Research, National Cancer Institute, 9000 Rockville Pike, Bethesda, 20892, MarylandTitle: Mammary gland, stem cells and breast cancer Section II: The genetic background of breast cancerBarbara L. Weber, Abramson Family Cancer Research Institute, University of Pennsylvania Cancer Center, 514 BRB II/III, 421 Curie Blvd, Philadelphia, PA 19104, USATitle: The genetic of breast cancer: application in clinical practiceAshok R. Venkitaraman, University of Cambridge, CR UK Department of Oncology and The Medical Research Council Cancer Cell Unit, Hutchison/MRC Research Centre, Hills Road, Cambridge, CB2 2XZ, U.KTitle: Cancerogenesis associated with mutations in BRCA genes Section III: Epigenetic and molecular alterations in breast cancerNancy E. Davidson, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, 1650 Orleans Street, Room 409, Baltimore, MD 21231Title: DNA methylation in breast cancerAntonio Giordano, Sbarro Institute for Cancer Research and Molecular Medicine, College of Science and Technology, Temple University, 1900 North 12th Street, Philadelphia, PA 19122, USATitle: Alterations of cell cycle regulatory genes in breast cancerDavid S. Salomon, Tumor Growth Factor Section, Mammary Biology & Tumorigenesis Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bldg 10, Rm. 5B39, Bethesda, Maryland 20892Title: Role of the cripto (EGF-CFC) family in mammary gland development and neoplasiaWilliam J Gullick, Department of Biosciences, University of Kent at Canterbury, Canterbury, Kent CT2 7NJTitle: Type I growth factor receptors and their ligands in breast cancer: clinical significance and future prospects for treatmentWilliam J. Muller, Institute for Molecular Biology and Biotechnology, Department of Biology, McMaster University, Hamilton, Ontario, Canada L8S 4K1Title: Transgenic mouse models of breast cancer as model to study oncogene mediated signal transduction Section IV: New tools for diagnosis and prognostic assessment in breast cancerEric S. Lander, Whitehead Institute/MIT Center for Genome Research, One Kendall Square, Building 300, Cambridge, Massachusetts 02139, USATitle: Gene expression profiling in breast cancer: clinical applicationsEmanuel F. Petricoin III, Center for Applied Proteomics and Molecular Medicine, George Mason University, 10900 University Boulevard, MS 4E3, Manassas, VA 20110Title: Proteomics in breast cancer Section V: Novel therapeutic approachesErik P. Winer, Dana-Farber Cancer Institute, 44 Binney St, D1210, Boston, MA 02115, USA. Title: The endocrine therapy of breast cancer in the era of the aromatase inhibitorsNicola Normanno, Cell Biology and Preclinical Models Unit, INT-Fondazione Pascale, Naples, ItalyTitle: Signal transduction inhibitors for treatment and prevention of breast cancerJose Baselga, Vall d'Hebron, University Hospital, Department of Medical Oncology, Pg Vall d'Hebron, 119-129, E-08035 Barcelona, Spain.Title: Monoclonal antibodies in breast cancer therapy: current status and future developmentCarlos L. Arteaga, Department of Cancer Biology, Vanderbilt University Medical Center, 2220 Pierce Avenue, 777 PRB, Nashville, TN 37232 USATitle: TGFbeta antagonists: a novel approach fro treatment of breast cancer?Francesco Perrone, Clinical Trials Unit, INT-Fondazione Pascale, Naples, ItalyIntegration of target based agents in current protocols of breast cancer therapy, [SC: 0.00]

New book Booklooker.de
Syndikat Buchdienst
Shipping costs:Versandkostenfrei, Versand nach Deutschland (EUR 0.00)
Details...
(*) Book out-of-stock means that the book is currently not available at any of the associated platforms we search.
Current Clinical Oncology: Breast Cancer in the Post-Genomic Era - Giordano, Antonio (Hrsg.) / Normanno, Nicola (Hrsg.)
book is out-of-stock
(*)
Giordano, Antonio (Hrsg.) / Normanno, Nicola (Hrsg.):
Current Clinical Oncology: Breast Cancer in the Post-Genomic Era - Paperback

2013, ISBN: 9781607614661

[ED: Taschenbuch / Paperback], [PU: Humana Press Springer, Berlin], AUSFÜHRLICHERE BESCHREIBUNG: Breast Cancer is the most common tumor in women and the second leading cause of cancer deaths worldwide. Due to breakthroughs in gene profiling, the knowledge of the pathophysiology of the mammary gland had greatly increased over the last decade. In Breast Cancer in the Post Genomic Era, Antonio Giordano, Nicola Normanno, and a panel of international authorities in their field provide a comprehensive approach to the biology, diagnosis, prevention, and treatment of human breast carcinoma.The book provides a comprehensive approach to breast cancer, describing the use of gene profiling techniques to distinguish specific features of individual carcinomas, as well as emerging novel therapeutic approaches to treatment. Additional chapters cover the use of transgenic mice to model human breast cancer and the role of the EGF-CFC family in mammary gland development and neoplasia. Breast Cancer in the Post Genomic-Era succeeds in looking at breast cancer pathogenesis, diagnosis, and treatment under a more comprehensive light, and is a valuable resource for any Radiation or Surgical Oncologist, Cancer Biologist or Pathologist. INHALT: Potential Contributors and Temptative TitlesSection I: The biology of the mammary gland:Jose Russo, Breast Cancer Research Laboratory, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USATitle: Mammary gland development Gilbert H. Smith Mammary Biology and Tumorigenesis Laboratory, Center for Cancer Research, National Cancer Institute, 9000 Rockville Pike, Bethesda, 20892, MarylandTitle: Mammary gland, stem cells and breast cancer Section II: The genetic background of breast cancerBarbara L. Weber, Abramson Family Cancer Research Institute, University of Pennsylvania Cancer Center, 514 BRB II/III, 421 Curie Blvd, Philadelphia, PA 19104, USATitle: The genetic of breast cancer: application in clinical practiceAshok R. Venkitaraman, University of Cambridge, CR UK Department of Oncology and The Medical Research Council Cancer Cell Unit, Hutchison/MRC Research Centre, Hills Road, Cambridge, CB2 2XZ, U.KTitle: Cancerogenesis associated with mutations in BRCA genes Section III: Epigenetic and molecular alterations in breast cancerNancy E. Davidson, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, 1650 Orleans Street, Room 409, Baltimore, MD 21231Title: DNA methylation in breast cancerAntonio Giordano, Sbarro Institute for Cancer Research and Molecular Medicine, College of Science and Technology, Temple University, 1900 North 12th Street, Philadelphia, PA 19122, USATitle: Alterations of cell cycle regulatory genes in breast cancerDavid S. Salomon, Tumor Growth Factor Section, Mammary Biology & Tumorigenesis Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bldg 10, Rm. 5B39, Bethesda, Maryland 20892Title: Role of the cripto (EGF-CFC) family in mammary gland development and neoplasiaWilliam J Gullick, Department of Biosciences, University of Kent at Canterbury, Canterbury, Kent CT2 7NJTitle: Type I growth factor receptors and their ligands in breast cancer: clinical significance and future prospects for treatmentWilliam J. Muller, Institute for Molecular Biology and Biotechnology, Department of Biology, McMaster University, Hamilton, Ontario, Canada L8S 4K1Title: Transgenic mouse models of breast cancer as model to study oncogene mediated signal transduction Section IV: New tools for diagnosis and prognostic assessment in breast cancerEric S. Lander, Whitehead Institute/MIT Center for Genome Research, One Kendall Square, Building 300, Cambridge, Massachusetts 02139, USATitle: Gene expression profiling in breast cancer: clinical applicationsEmanuel F. Petricoin III, Center for Applied Proteomics and Molecular Medicine, George Mason University, 10900 University Boulevard, MS 4E3, Manassas, VA 20110Title: Proteomics in breast cancer Section V: Novel therapeutic approachesErik P. Winer, Dana-Farber Cancer Institute, 44 Binney St, D1210, Boston, MA 02115, USA. Title: The endocrine therapy of breast cancer in the era of the aromatase inhibitorsNicola Normanno, Cell Biology and Preclinical Models Unit, INT-Fondazione Pascale, Naples, ItalyTitle: Signal transduction inhibitors for treatment and prevention of breast cancerJose Baselga, Vall d'Hebron, University Hospital, Department of Medical Oncology, Pg Vall d'Hebron, 119-129, E-08035 Barcelona, Spain.Title: Monoclonal antibodies in breast cancer therapy: current status and future developmentCarlos L. Arteaga, Department of Cancer Biology, Vanderbilt University Medical Center, 2220 Pierce Avenue, 777 PRB, Nashville, TN 37232 USATitle: TGFbeta antagonists: a novel approach fro treatment of breast cancer?Francesco Perrone, Clinical Trials Unit, INT-Fondazione Pascale, Naples, ItalyIntegration of target based agents in current protocols of breast cancer therapy

New book Booklooker.de
Syndikat Buchdienst
Shipping costs:zzgl. Versandkosten, plus shipping costs
Details...
(*) Book out-of-stock means that the book is currently not available at any of the associated platforms we search.
Breast Cancer in the Post-Genomic Era - Giordano, Antonio / Normanno, Nicola
book is out-of-stock
(*)
Giordano, Antonio / Normanno, Nicola:
Breast Cancer in the Post-Genomic Era - new book

ISBN: 1607614669

ID: 15354649899

[EAN: 9781607614661], Neubuch, Publisher/Verlag: Springer, Berlin | Breast Cancer is the most common tumor in women and the second leading cause of cancer deaths worldwide. Due to breakthroughs in gene profiling, the knowledge of the pathophysiology of the mammary gland had greatly increased over the last decade. In Breast Cancer in the Post Genomic Era, Antonio Giordano, Nicola Normanno, and a panel of international authorities in their field provide a comprehensive approach to the biology, diagnosis, prevention, and treatment of human breast carcinoma. The book provides a comprehensive approach to breast cancer, describing the use of gene profiling techniques to distinguish specific features of individual carcinomas, as well as emerging novel therapeutic approaches to treatment. Additional chapters cover the use of transgenic mice to model human breast cancer and the role of the EGF-CFC family in mammary gland development and neoplasia. Breast Cancer in the Post Genomic-Era succeeds in looking at breast cancer pathogenesis, diagnosis, and treatment under a more comprehensive light, and is a valuable resource for any Radiation or Surgical Oncologist, Cancer Biologist or Pathologist. | Potential Contributors and Temptative Titles Section I: The biology of the mammary gland: Jose Russo, Breast Cancer Research Laboratory, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA Title: Mammary gland development Gilbert H. Smith Mammary Biology and Tumorigenesis Laboratory, Center for Cancer Research, National Cancer Institute, 9000 Rockville Pike, Bethesda, 20892, Maryland Title: Mammary gland, stem cells and breast cancer Section II: The genetic background of breast cancer Barbara L. Weber, Abramson Family Cancer Research Institute, University of Pennsylvania Cancer Center, 514 BRB II/III, 421 Curie Blvd, Philadelphia, PA 19104, USA Title: The genetic of breast cancer: application in clinical practice Ashok R. Venkitaraman, University of Cambridge, CR UK Department of Oncology and The Medical Research Council Cancer Cell Unit, Hutchison/MRC Research Centre, Hills Road, Cambridge, CB2 2XZ, U.K Title: Cancerogenesis associated with mutations in BRCA genes Section III: Epigenetic and molecular alterations in breast cancer Nancy E. Davidson, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, 1650 Orleans Street, Room 409, Baltimore, MD 21231 Title: DNA methylation in breast cancer Antonio Giordano, Sbarro Institute for Cancer Research and Molecular Medicine, College of Science and Technology, Temple University, 1900 North 12th Street, Philadelphia, PA 19122, USA Title: Alterations of cell cycle regulatory genes in breast cancer David S. Salomon, Tumor Growth Factor Section, Mammary Biology & Tumorigenesis Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bldg 10, Rm. 5B39, Bethesda, Maryland 20892 Title: Role of the cripto (EGF-CFC) family in mammary gland development and neoplasia William J Gullick, Department of Biosciences, University of Kent at Canterbury, Canterbury, Kent CT2 7NJ Title: Type I growth factor receptors and their ligands in breast cancer: clinical significance and future prospects for treatment William J. Muller, Institute for Molecular Biology and Biotechnology, Department of Biology, McMaster University, Hamilton, Ontario, Canada L8S 4K1 Title: Transgenic mouse models of breast cancer as model to study oncogene mediated signal transduction Section IV: New tools for diagnosis and prognostic assessment in breast cancer Eric S. Lander, Whitehead Institute/MIT Center for Genome Research, One Kendall Square, Building 300, Cambridge, Massachusetts 02139, USA Title: Gene expression profiling in breast cancer: clinical applications Emanuel F. Petricoin III, Center for Applied Proteomics and Molecular Medicine, George Mason University, 10900 University Boulevard, MS 4E3, Manassas, VA 20110 Title: Proteomics in breast cancer Section V: Novel therapeutic approaches Erik P. Winer, Dana-Farber

New book Abebooks.de
English-Book-Service - A Fine Choice, Waldshut-Tiengen, Germany [1048135] [Rating: 4 (von 5)]
NEW BOOK Shipping costs:Versandkostenfrei (EUR 0.00)
Details...
(*) Book out-of-stock means that the book is currently not available at any of the associated platforms we search.
Breast Cancer in the Post-Genomic Era - ValueXY
book is out-of-stock
(*)
ValueXY:
Breast Cancer in the Post-Genomic Era - new book

ISBN: 9781607614661

ID: e546fd3eba7fa4b4b5c821a67f7af341

Breast Cancer is the most common tumor in women and the second leading cause of cancer deaths worldwide. Due to breakthroughs in gene profiling, the knowledge of the pathophysiology of the mammary gland had greatly increased over the last decade. In Breast Cancer in the Post Genomic Era, Antonio Giordano, Nicola Normanno, and a panel of international authorities in their field provide a comprehensive approach to the biology, diagnosis, prevention, and treatment of human breast carcinoma. The book provides a comprehensive approach to breast cancer, describing the use of gene profiling techniques to distinguish specific features of individual carcinomas, as well as emerging novel therapeutic approaches to treatment. Additional chapters cover the use of transgenic mice to model human breast cancer and the role of the EGF-CFC family in mammary gland development and neoplasia. Breast Cancer in the Post Genomic-Era succeeds in looking at breast cancer pathogenesis, diagnosis, and treatment under a more comprehensive light, and is a valuable resource for any Radiation or Surgical Oncologist, Cancer Biologist or Pathologist. Buch / Broschur

New book derClub.de
Nr. 1878445 Shipping costs:, Lieferung nach DE. (EUR 0.00)
Details...
(*) Book out-of-stock means that the book is currently not available at any of the associated platforms we search.
Breast Cancer in the Post-Genomic Era - Antonio Giordano; Nicola Normanno
book is out-of-stock
(*)
Antonio Giordano; Nicola Normanno:
Breast Cancer in the Post-Genomic Era - Paperback

2010, ISBN: 9781607614661

ID: 11121036

2009, Softcover, Buch, [PU: Humana Press Inc.]

New book Lehmanns.de
Shipping costs:sofort lieferbar, , Versandkostenfrei innerhalb der BRD (EUR 0.00)
Details...
(*) Book out-of-stock means that the book is currently not available at any of the associated platforms we search.

Details of the book
Breast Cancer in the Post-Genomic Era
Author:

Antonio Giordano

Title:
ISBN:

Breast Cancer is the most common tumor in women and the second leading cause of cancer deaths worldwide. Due to breakthroughs in gene profiling, the knowledge of the pathophysiology of the mammary gland had greatly increased over the last decade. In Breast Cancer in the Post Genomic Era, Antonio Giordano, Nicola Normanno, and a panel of international authorities in their field provide a comprehensive approach to the biology, diagnosis, prevention, and treatment of human breast carcinoma. The book provides a comprehensive approach to breast cancer, describing the use of gene profiling techniques to distinguish specific features of individual carcinomas, as well as emerging novel therapeutic approaches to treatment. Additional chapters cover the use of transgenic mice to model human breast cancer and the role of the EGF-CFC family in mammary gland development and neoplasia. Breast Cancer in the Post Genomic-Era succeeds in looking at breast cancer pathogenesis, diagnosis, and treatment under a more comprehensive light, and is a valuable resource for any Radiation or Surgical Oncologist, Cancer Biologist or Pathologist.

Details of the book - Breast Cancer in the Post-Genomic Era


EAN (ISBN-13): 9781607614661
ISBN (ISBN-10): 1607614669
Hardcover
Paperback
Publishing year: 201307
Publisher: Springer-Verlag GmbH
230 Pages
Language: Englisch

Book in our database since 31.10.2009 19:21:07
Book found last time on 22.06.2015 21:13:38
ISBN/EAN: 9781607614661

ISBN - alternate spelling:
1-60761-466-9, 978-1-60761-466-1


< to archive...
Related books